BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27566854)

  • 1. Boston Keratoprosthesis Type 1: A Randomized Controlled Trial of Fresh versus Frozen Corneal Donor Carriers with Long-Term Follow-up.
    Muzychuk AK; Robert MC; Dao S; Harissi-Dagher M
    Ophthalmology; 2017 Jan; 124(1):20-26. PubMed ID: 27566854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frozen versus fresh corneal graft carriers in Boston keratoprosthesis surgery: 10-year outcomes.
    Sabeti S; Daoud R; Robert MC; Harissi-Dagher M
    Can J Ophthalmol; 2022 Apr; 57(2):127-133. PubMed ID: 33781724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
    Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
    Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
    Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
    Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
    Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
    Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor Corneal Transplantation vs Boston Type 1 Keratoprosthesis in Patients with Previous Graft Failures: A Retrospective Single Center Study (An American Ophthalmological Society Thesis).
    Akpek EK; Cassard SD; Dunlap K; Hahn S; Ramulu PY
    Trans Am Ophthalmol Soc; 2015; 113():T3. PubMed ID: 26538773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
    Aravena C; Yu F; Aldave AJ
    Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boston type 1 keratoprosthesis: the CHUM experience.
    Robert MC; Harissi-Dagher M
    Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glaucoma associated with Boston type I keratoprosthesis.
    Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
    Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
    Geoffrion D; Harissi-Dagher M
    Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of bilateral sequential implantation of the Boston keratoprosthesis type 1.
    Vaillancourt L; Papanagnu E; Elfekhfakh M; Fadous R; Harissi-Dagher M
    Can J Ophthalmol; 2017 Feb; 52(1):80-84. PubMed ID: 28237154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term visual outcomes of Boston type I keratoprosthesis in Canada].
    Aoun T; Harissi-Dagher M
    J Fr Ophtalmol; 2023 Dec; 46(10):1212-1221. PubMed ID: 37867123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
    Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
    Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
    Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
    Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.